We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Balloon Catheter Delivery of Helper-dependent Adenoviral Vector Results in Sustained, Therapeutic hFIX Expression in Rhesus Macaques.
- Authors
Brunetti-Pierri, Nicola; Liou, Aimee; Patel, Priti; Palmer, Donna; Grove, Nathan; Finegold, Milton; Piccolo, Pasquale; Donnachie, Elizabeth; Rice, Karen; Beaudet, Arthur; Mullins, Charles; Ng, Philip
- Abstract
Hemophilia B is an excellent candidate for gene therapy because low levels of factor IX (FIX) (≥1%) result in clinically significant improvement of the bleeding diathesis. Helper-dependent adenoviral (HDAd) vectors can mediate long-term transgene expression without chronic toxicity. To determine the potential for HDAd-mediated liver-directed hemophilia B gene therapy, we administered an HDAd expressing hFIX into rhesus macaques through a novel and minimally invasive balloon occlusion catheter-based method that permits preferential, high-efficiency hepatocyte transduction with low, subtoxic vector doses. Animals given 1 × 1012 and 1 × 1011 virus particle (vp)/kg achieved therapeutic hFIX levels for the entire observation period (up to 1,029 days). At 3 × 1010 and 1 × 1010 vp/kg, only subtherapeutic hFIX levels were achieved which were not sustained long-term. Balloon occlusion administration of HDAd was well tolerated with negligible toxicity. Five of six animals developed inhibitors to hFIX. These results provide important information in assessing the clinical utility of HDAd for hemophilia B gene therapy.
- Subjects
HEMOPHILIA; GENE therapy; TRANSGENE expression; ARTERIAL occlusions; RHESUS monkeys
- Publication
Molecular Therapy, 2012, Vol 20, Issue 10, p1863
- ISSN
1525-0016
- Publication type
Article
- DOI
10.1038/mt.2012.143